(Q43812193)

27 November 2017

title

SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals (English)

1 reference

27 November 2017

Carey GJ

1

1 reference

27 November 2017

Billard W

2

1 reference

27 November 2017

Binch H 3rd

3

1 reference

27 November 2017

Cohen-Williams M

4

1 reference

27 November 2017

Crosby G

5

1 reference

27 November 2017

Grzelak M

6

1 reference

27 November 2017

Guzik H

7

1 reference

27 November 2017

Kozlowski JA

8

1 reference

27 November 2017

Lowe DB

9

1 reference

27 November 2017

Pond AJ

10

1 reference

27 November 2017

Tedesco RP

11

1 reference

27 November 2017

Watkins RW

12

1 reference

27 November 2017

Coffin VL

13

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

European Journal of Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

431

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

189-200

1 reference

The effects of physostigmine and scopolamine on recognition memory in monkeys.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Facilitation of memory storage by the acetylcholine M2 muscarinic receptor antagonist AF-DX 116.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from Chinese hamster ovary-m1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

The cholinergic hypothesis of Alzheimer's disease: a review of progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

The effect of pirenzepine on spatial learning in the Morris Water Maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

SCH 57790: a novel M2 receptor selective antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Evidence for a preferential involvement of M1 muscarinic receptors in representational memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Comparison of the effects of scopolamine and methylscopolamine on the performance of a fixed-ratio discrimination in squirrel monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Cholinergic improvement of a naturally-occurring memory deficit in the young rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Effects of M2 antagonists on in vivo hippocampal acetylcholine levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

Molecular biology of muscarinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901440-6

10.1016/S0014-2999(01)01440-6

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference